Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,658
Closed -$362K 468
2025
Q4
$362K Sell
2,658
-669
-20% -$96.2K 0.08% 197
2025
Q3
$491K Sell
3,327
-2,679
-45% -$372K 0.09% 220
2025
Q2
$777K Sell
6,006
-1,709
-22% -$207K 0.13% 183
2025
Q1
$922K Buy
+7,715
New +$956K 0.18% 130

Other funds holding XYL

111 Capital's XYL Position: Q1 2026 in Review

111 Capital sold out of Xylem (XYL) in Q1 2026, closing a stake of 2,658 shares — an estimated $362K sold.

111 Capital first reported a position in XYL in Q1 2025 and held it in 4 quarters. The position peaked at $922K in Q1 2025. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • 111 Capital reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • 111 Capital sold 2,658 Xylem shares in Q1 2026, an estimated $362K.
  • 111 Capital first reported a position in Xylem in Q1 2025 and held it in 4 quarters.
  • 111 Capital's Xylem position peaked at $922K in Q1 2025.
  • 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on 111 Capital's 13F filing for Q1 2026, filed 11 May 2026.